Pyrludimide (KX-826) or Breezula (clascoterone)
    Treatment 3/25/2026

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💊 Finasteride (oral) various doses
    💧 Finasteride (topical) 0.05%
    💊 Dutasteride (oral) various doses
    💧 Pyrilutamide (KX-826) (topical) 0.9%
    💧 Breezula (clascoterone) (topical) 1% or 5%
    the tone is 😐 neutral.

    Other terms

    The conversation is about hair loss treatments, specifically Pyrludimide (KX-826) and Breezula (clascoterone), with the user unable to tolerate finasteride and dutasteride. The user plans to use these treatments alongside minoxidil, considering the efficacy and availability of each option.
    View this post in the Community →

    Similar Community Posts Join

    5 / 78 results

      community Why so much hate for PP405 all of a sudden?

      in Technology  48 upvotes 11 months ago
      PP405 is a new hair loss treatment facing mixed reactions due to initial hype and insufficient data. Some are hopeful, but many doubt its effectiveness compared to minoxidil and finasteride.

      community What to look Forward to in 2025

      in Research/Science  20 upvotes 1 year ago
      Hair loss treatments are advancing, with Coegin Pharma's FOL005 expected this year and Breezula potentially later. Pyrilutamide is available but not very effective, while Kintor's products face skepticism; traditional treatments like finasteride and minoxidil remain dominant.

    Related Research

    — no results